We are live on ! Find out more
ACG

Anchorage Capital Group Portfolio holdings

AUM $436M
1-Year Est. Return 38.51%
This Fund
S&P 500
This Quarter Est. Return
+21.27%
1 Year Est. Return
-38.51%
3 Year Est. Return
-18.86%
5 Year Est. Return
-55.07%
10 Year Est. Return
+90.94%
AUM
$382M
AUM Growth
+$58M
Cap. Flow
-$7.19M
Cap. Flow %
-1.88%
Top 10 Hldgs %
100%
Holding
8
New
Increased
Reduced
1
Closed
1

Top Buys

No buys this quarter

Sector Composition

Rank Sector Weight
1 Communication Services 47.66%
2 Technology 30.92%
3 Healthcare 18.33%
4 Consumer Discretionary 1.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FYBR
1
DELISTED
Frontier Communications
FYBR
$182M 47.66%
5,123,545
S icon
2
SentinelOne
S
$6.17B
$118M 30.92%
4,937,053
ROIV icon
3
Roivant Sciences
ROIV
$25.1B
$55.8M 14.6%
4,832,642
DNA icon
4
Ginkgo Bioworks
DNA
$510M
$14.2M 3.73%
1,746,363
-2
-0% -$20
AMBP icon
5
Ardagh Metal Packaging
AMBP
$2.99B
$4.71M 1.23%
1,250,000
AMBP.WS
6
DELISTED
Ardagh Metal Packaging Warrants
AMBP.WS
$52.2K 0.01%
1,245,385
DNA.WS
7
DELISTED
Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share
DNA.WS
-50,000
Closed -$1.41K

Similar funds

Anchorage Capital Group's Q3 2024 Portfolio in Review

As of Q3 2024, Anchorage Capital Group held 8 positions worth $382M, up 18% from $324M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Anchorage Capital Group's Q3 2024 filing shows 1 reduced and 1 closed positions. The largest sale was Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share, an estimated $1.41K.

By sector, the portfolio is most concentrated in Communication Services at 48% of assets, up from 41% a quarter earlier, followed by Technology and Healthcare.

  • Anchorage Capital Group's biggest Q3 2024 reduction was Ginkgo Bioworks, cutting an estimated $20.
  • Anchorage Capital Group fully exited Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share in Q3 2024, selling an estimated $1.41K.
  • Anchorage Capital Group's ten largest holdings make up 100% of its $382M portfolio in Q3 2024.
  • Anchorage Capital Group opened 0 new positions and closed 1 in Q3 2024.
  • Anchorage Capital Group's portfolio value rose 18% quarter-over-quarter to $382M.

Based on Anchorage Capital Group's 13F filing for Q3 2024, filed 14 Nov 2024.